Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
10698723
PubMed Central
PMC1637778
DOI
10.1289/ehp.108-1637778
PII: sc271_5_1835
Knihovny.cz E-zdroje
- MeSH
- karcinogeny analýza toxicita MeSH
- lidé MeSH
- molekulární epidemiologie * MeSH
- mutageny analýza toxicita MeSH
- pracovní expozice statistika a číselné údaje MeSH
- vystavení vlivu životního prostředí statistika a číselné údaje MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- karcinogeny MeSH
- mutageny MeSH
Molecular epidemiology is a new and evolving area of research, combining laboratory measurement of internal dose, biologically effective dose, biologic effects, and influence of individual susceptibility with epidemiologic methodologies. Biomarkers evaluated were selected according to basic scheme: biomarkers of exposure--metabolites in urine, DNA adducts, protein adducts, and Comet assay parameters; biomarkers of effect--chromosomal aberrations, sister chromatid exchanges, micronuclei, mutations in the hypoxanthine-guanine phosphoribosyltransferase gene, and the activation of oncogenes coding for p53 or p21 proteins as measured on protein levels; biomarkers of susceptibility--genetic polymorphisms of genes CYP1A1, GSTM1, GSTT1, NAT2. DNA adducts measured by 32P-postlabeling are the biomarker of choice for the evaluation of exposure to polycyclic aromatic hydrocarbons. Protein adducts are useful as a biomarker for exposure to tobacco smoke (4-aminobiphenyl) or to smaller molecules such as acrylonitrile or 1,3-butadiene. Of the biomarkers of effect, the most common are cytogenetic end points. Epidemiologic studies support the use of chromosomal breakage as a relevant biomarker of cancer risk. The use of the Comet assay and methods analyzing oxidative DNA damage needs reliable validation for human biomonitoring. Until now there have not been sufficient data to interpret the relationship between genotypes, biomarkers of exposure, and biomarkers of effect for assessing the risk of human exposure to mutagens and carcinogens.
Zobrazit více v PubMed
Mutat Res. 1997 Aug 14;392(3):261-8 PubMed
Carcinogenesis. 1997 Sep;18(9):1833-6 PubMed
Environ Mol Mutagen. 1997;30(2):97-111 PubMed
Environ Mol Mutagen. 1997;30(2):119-30 PubMed
Environ Mol Mutagen. 1997;30(2):131-8 PubMed
Environ Mol Mutagen. 1997;30(2):139-46 PubMed
Environ Mol Mutagen. 1997;30(2):147-52 PubMed
Environ Mol Mutagen. 1997;30(2):184-95 PubMed
Hum Exp Toxicol. 1997 Oct;16(10):589-95 PubMed
Mutat Res. 1997 Oct 24;393(3):283-8 PubMed
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):288-93 PubMed
Occup Environ Med. 1997 Sep;54(9):662-6 PubMed
Mutat Res. 1997 Nov 27;394(1-3):37-44 PubMed
Mutat Res. 1997 Nov 28;381(2):163-70 PubMed
Mutat Res. 1997 Nov 28;381(2):217-26 PubMed
Environ Mol Mutagen. 1997;30(4):396-402 PubMed
Cancer Epidemiol Biomarkers Prev. 1998 Jan;7(1):3-11 PubMed
Environ Health Perspect. 1998 Jun;106 Suppl 3:821-6 PubMed
Environ Mol Mutagen. 1998;31(4):301-10 PubMed
Biotherapy. 1998;11(2-3):155-67 PubMed
Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):571-7 PubMed
Mutat Res. 1998 May 25;400(1-2):215-31 PubMed
Environ Mol Mutagen. 1998;32(1):17-24 PubMed
Mutat Res. 1998 Jul 8;415(1-2):25-33 PubMed
Environ Health Perspect. 1998 Aug;106 Suppl 4:937-46 PubMed
Mutat Res. 1998 Jul 31;415(3):185-90 PubMed
Mutat Res. 1998 Aug 7;416(1-2):67-84 PubMed
Mutat Res. 1998 Jul 17;403(1-2):55-64 PubMed
Mutat Res. 1998 Sep 1;417(1):9-17 PubMed
Carcinogenesis. 1998 Aug;19(8):1389-92 PubMed
Mutat Res. 1998 Sep 20;405(2):171-8 PubMed
Mutat Res. 1998 Sep 20;405(2):237-45 PubMed
Carcinogenesis. 1997 Feb;18(2):345-50 PubMed
Carcinogenesis. 1997 Mar;18(3):503-9 PubMed
Cancer Epidemiol Biomarkers Prev. 1997 Mar;6(3):193-9 PubMed
J Cancer Res Clin Oncol. 1997;123(3):141-51 PubMed
Mutat Res. 1997 Mar 17;389(2-3):227-35 PubMed
Mutat Res. 1997 Mar 17;389(2-3):243-6 PubMed
Carcinogenesis. 1997 Apr;18(4):817-23 PubMed
Mutat Res. 1997 Apr 24;390(1-2):153-9 PubMed
Mutat Res. 1997 May 1;383(3):213-21 PubMed
Mutat Res. 1997 Apr 29;375(2):183-93 PubMed
Mutat Res. 1997 Jun;386(3):219-28 PubMed
Mutat Res. 1997 Jun 9;377(1):89-93 PubMed
Mutat Res. 1997 Jun 9;377(1):95-104 PubMed
Mutat Res. 1997 Jun 9;377(1):115-23 PubMed
Environ Health Perspect. 1997 May;105(5):464-5 PubMed
Am J Epidemiol. 1998 Feb 1;147(3):309-14 PubMed
Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):147-55 PubMed
Mutagenesis. 1998 Jan;13(1):99-103 PubMed
Carcinogenesis. 1998 Mar;19(3):413-8 PubMed
Mutat Res. 1998 Jan 30;412(2):177-86 PubMed
Environ Mol Mutagen. 1998;31(3):218-27 PubMed
Environ Mol Mutagen. 1998;31(3):228-42 PubMed
Carcinogenesis. 1998 Apr;19(4):695-8 PubMed
Mutat Res. 1998 Feb 13;412(3):261-9 PubMed
Mutat Res. 1998 Feb 13;412(3):293-8 PubMed
Cancer Res. 1998 May 15;58(10):2176-81 PubMed
Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):545-51 PubMed
Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):823-9 PubMed
Mutat Res. 1998 Oct 12;418(2-3):93-100 PubMed
Nat Med. 1998 Oct;4(10):1144-51 PubMed
Carcinogenesis. 1998 Sep;19(9):1565-71 PubMed
Environ Mol Mutagen. 1998;32(2):121-9 PubMed
Environ Mol Mutagen. 1998;32(2):130-8 PubMed
Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):929-40 PubMed
Mutat Res. 1998 Nov 9;419(1-3):123-30 PubMed
Mutat Res. 1998 Nov 9;419(1-3):145-54 PubMed
Carcinogenesis. 1998 Nov;19(11):1955-61 PubMed
Carcinogenesis. 1998 Nov;19(11):1963-8 PubMed
Environ Mol Mutagen. 1998;32(4):301-13 PubMed
Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):561-5 PubMed
Mutat Res. 1999 Jul 15;443(1-2):139-47 PubMed
Environ Health Perspect. 1999 Jun;107 Suppl 3:451-60 PubMed
Environ Mol Mutagen. 1999;34(1):52-6 PubMed
Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):733-9 PubMed
Mutat Res. 1999 Jul 16;428(1-2):177-85 PubMed
Mutat Res. 1999 Jul 16;428(1-2):197-202 PubMed
Mutat Res. 1999 Jul 16;428(1-2):203-15 PubMed
Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):91-6 PubMed
Mutat Res. 1999 Feb 19;439(2):249-57 PubMed
Mutat Res. 1999 Feb 19;439(2):277-85 PubMed
Mutat Res. 1999 Feb 2;439(1):97-104 PubMed
Environ Health Perspect. 1999 Mar;107(3):233-8 PubMed
Mutat Res. 1999 Mar 8;424(1-2):9-21 PubMed
Mutat Res. 1999 Mar 8;424(1-2):143-53 PubMed
Mutat Res. 1999 Mar 8;424(1-2):249-61 PubMed
Mutat Res. 1999 Mar 8;424(1-2):275-86 PubMed
Mutat Res. 1999 Mar 15;440(1):19-25 PubMed
Mutat Res. 1999 Mar 15;440(1):45-58 PubMed
Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):303-10 PubMed
Mutat Res. 1999 Apr 6;440(2):195-204 PubMed
Crit Rev Toxicol. 1999 Mar;29(2):129-68 PubMed
Mutat Res. 1999 Apr 26;441(1):11-9 PubMed
Mutat Res. 1999 Apr 26;441(1):115-27 PubMed
Mutat Res. 1999 Apr 26;441(1):135-44 PubMed
Environ Res. 1999 May;80(4):369-82 PubMed
Mutat Res. 1999 May 17;441(2):225-37 PubMed
Environ Health Perspect. 1999 Jun;107(6):469-74 PubMed
Environ Health Perspect. 1999 Jun;107(6):475-80 PubMed
Environ Health Perspect. 1999 Jun;107(6):501-5 PubMed
Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):427-31 PubMed
Mutagenesis. 1999 May;14(3):301-15 PubMed
Mutagenesis. 1994 May;9(3):269-72 PubMed
Mutat Res. 1994 Oct-Dec;313(2-3):117-29 PubMed
Epidemiology. 1995 Jul;6(4):455-7 PubMed
Mutat Res. 1997 Jan 15;388(1):85-95 PubMed
Carcinogenesis. 1997 Feb;18(2):339-44 PubMed
Environ Health Perspect. 1997 Jun;105 Suppl 4:907-12 PubMed
Mutat Res. 1997 Aug 1;378(1-2):51-63 PubMed
Mutat Res. 1997 Aug 1;378(1-2):65-75 PubMed
Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer
Ambient air pollution and pregnancy outcomes: a review of the literature